Redmond Asset Management LLC reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,741 shares of the pharmacy operator’s stock after selling 499 shares during the quarter. Redmond Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $1,134,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. TRUE Private Wealth Advisors purchased a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth $38,000. Amica Retiree Medical Trust increased its position in Walgreens Boots Alliance by 59.8% during the 2nd quarter. Amica Retiree Medical Trust now owns 8,962 shares of the pharmacy operator’s stock valued at $490,000 after buying an additional 3,354 shares in the last quarter. Advisory Services Network LLC increased its position in Walgreens Boots Alliance by 52.6% during the 2nd quarter. Advisory Services Network LLC now owns 21,382 shares of the pharmacy operator’s stock valued at $1,169,000 after buying an additional 7,366 shares in the last quarter. Coastal Investment Advisors Inc. increased its position in Walgreens Boots Alliance by 80.4% during the 2nd quarter. Coastal Investment Advisors Inc. now owns 10,434 shares of the pharmacy operator’s stock valued at $569,000 after buying an additional 4,649 shares in the last quarter. Finally, Westpac Banking Corp increased its position in Walgreens Boots Alliance by 17.8% during the 2nd quarter. Westpac Banking Corp now owns 135,856 shares of the pharmacy operator’s stock valued at $7,427,000 after buying an additional 20,506 shares in the last quarter. Hedge funds and other institutional investors own 61.97% of the company’s stock.
Several research analysts recently issued reports on the company. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Monday, June 24th. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. JPMorgan Chase & Co. reduced their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price on the stock. in a research report on Monday, June 10th. Finally, Guggenheim assumed coverage on Walgreens Boots Alliance in a research report on Thursday, April 18th. They set a “neutral” rating and a $59.00 target price on the stock. Six analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $63.82.
Shares of WBA stock traded down $0.71 during mid-day trading on Thursday, reaching $49.70. The stock had a trading volume of 2,861,990 shares, compared to its average volume of 4,389,901. The business has a fifty day moving average of $54.33. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. The company has a market cap of $46.96 billion, a price-to-earnings ratio of 8.25, a price-to-earnings-growth ratio of 1.30 and a beta of 0.81. Walgreens Boots Alliance Inc has a 1-year low of $49.31 and a 1-year high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. The business had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the company earned $1.53 earnings per share. Analysts forecast that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be issued a $0.458 dividend. The ex-dividend date of this dividend is Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.69%. Walgreens Boots Alliance’s dividend payout ratio is currently 29.24%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: Why do companies pay special dividends?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.